Catalyst

Slingshot members are tracking this event:

Heron Therapeutics' (HRTX) HTX-011 in Post operative pain PDUFA date set for May 12, 2021

Source Link:
https://www.prnewswire.com/news-releases/heron-therapeutics-highlights-progress-in-pain-management-and-cinv-franchises-and-announces-new-development-program-301204895.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
HRTX Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
May 12, 2021
Occurred Source:
https://herontherapeutics.gcs-web.com/news-releases/news-release-details/heron-therapeutics-announces-us-fda-approval-zynreleftm-htx-011
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Htx-011, Post Operative Pain
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.